What is Amphastar Pharmaceuticals's debt issuance proceeds?

Amphastar Pharmaceuticals (AMPH) reported debt issuance proceeds of $172K in Q3 2025.

How has Amphastar Pharmaceuticals's debt issuance proceeds changed year-over-year?

Amphastar Pharmaceuticals's debt issuance proceeds decreased by 98.2% year-over-year, from $9.51M to $172K.

What does debt issuance proceeds mean?

Cash received from issuing bonds, notes, term loans, and other debt instruments in the capital markets or from bank lending.

Amphastar Pharmaceuticals AMPH Debt Issuance Proceeds

Debt Issuance Proceeds at other companies

Opko HealthOPK

$8.49M+51.3%

AptarGroupATR

$5.04M+3,962%

Amneal Pharmaceuticals, Inc.AMRX

$134.67M—

AbbVieABBV

$7.99B+100%

AbbottABT

$19.86B+1,985,900%

BioCryst PharmaceuticalsBCRX

$400M—

Other financials

Income statement

See full

Revenue$171.2M+0.4%

Gross profit$70.3M-17.5%

Operating income$13.6M-63.5%

Net income$6.4M-74.6%

EPS (diluted)$0.14-72.5%

Balance sheet

See full

Cash & equivalents$170.9M-6.5%

Total debt$686.6M+5.2%

Total equity$445.5M—

Total assets$1.6B+1.3%

Cash flow

See full

Operating cash flow$47.8M+36.4%

CapEx$9.5M-11.1%

Free cash flow$38.3M+57.2%

Valuation

See full

Market cap$926.83M-19.9%

Enterprise value$1.44B-11.3%

P/E11.7×+3.5×

P/S1.3×-0.3×

Profitability

See full

Gross margin47.3%-3.2pp

Operating margin16.2%-10.4pp

Net margin11%-8.4pp

FCF margin18.8%-1.8pp

Returns & leverage

See full

Return on equity14.7%—

Debt / equity0.2×—

Current ratio3.9×+0.9×

Where this comes from

Reported directly by Amphastar Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromLinesOfCredit.

The official record: Amphastar Pharmaceuticals’s 10-Q, filed November 6, 2025, on SEC EDGAR. View the filing →

Ask your AI about Amphastar Pharmaceuticals's debt issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Amphastar Pharmaceuticals's debt issuance proceeds?: Amphastar Pharmaceuticals (AMPH) reported debt issuance proceeds of $172K in Q3 2025.
How has Amphastar Pharmaceuticals's debt issuance proceeds changed year-over-year?: Amphastar Pharmaceuticals's debt issuance proceeds decreased by 98.2% year-over-year, from $9.51M to $172K.
What does debt issuance proceeds mean?: Cash received from issuing bonds, notes, term loans, and other debt instruments in the capital markets or from bank lending.